Gilder Gagnon Howe & CO LLC Eq Rx, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.94 - $5.99 $106,487 - $678,577	-113,285 Reduced 58.6%	80,028 $396,000
Q2 2022 Aug 15, 2022	SELL	$3.2 - $5.69 $761,046 - $1.35 Million	-237,827 Reduced 55.16%	193,313 $907,000
Q1 2022 May 16, 2022	SELL	$2.8 - $7.39 $775,790 - $2.05 Million	-277,068 Reduced 39.12%	431,140 $1.78 Million
Q4 2021 Feb 14, 2022	BUY	$5.92 - $9.98 $4.19 Million - $7.07 Million	708,208 New	708,208 $4.83 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.